At a glance
ClinicalIndex Comparison RecordN/ACompleted· 82 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Italian Angelman Syndrome Registry Project
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS·observational·Posted Aug 28, 2018·Updated Feb 27, 2026
In Brief
An observational study for Angelman Syndrome. Completed, enrolled 82 participants across 1 site.
Detailed Summary
The Italian Angelman Registry is a national registry for patients with Angelman Syndrome. No experimental intervention is involved in participation. The data provided are stored in the registry according the EU General Data Protection Regulation (GDPR, enforced on 25 May 2018), unless participants wish to withdraw their child/ adult's information from the registry.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAngelman Syndrome
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedAug 2018
Primary CompletionFeb 2021
Study CompletionFeb 2022
TodayJul 2026
First PostedAug 28, 2018
Enrollment StartFeb 16, 2018
Primary CompletionFeb 16, 2021
Study CompletionFeb 16, 2022
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 7.8 years ago